These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 23775608)

  • 1. Direct cloning and tetramer staining to measure the frequency of intestinal gluten-reactive T cells in celiac disease.
    Bodd M; Ráki M; Bergseng E; Jahnsen J; Lundin KE; Sollid LM
    Eur J Immunol; 2013 Oct; 43(10):2605-12. PubMed ID: 23775608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing possible celiac disease by an HLA-DQ2-gliadin Tetramer Test.
    Brottveit M; Ráki M; Bergseng E; Fallang LE; Simonsen B; Løvik A; Larsen S; Løberg EM; Jahnsen FL; Sollid LM; Lundin KE
    Am J Gastroenterol; 2011 Jul; 106(7):1318-24. PubMed ID: 21364548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Cells Are the Most Abundant Gluten Peptide MHC-expressing Cells in Inflamed Intestinal Tissues From Patients With Celiac Disease.
    Høydahl LS; Richter L; Frick R; Snir O; Gunnarsen KS; Landsverk OJB; Iversen R; Jeliazkov JR; Gray JJ; Bergseng E; Foss S; Qiao SW; Lundin KEA; Jahnsen J; Jahnsen FL; Sandlie I; Sollid LM; Løset GÅ
    Gastroenterology; 2019 Apr; 156(5):1428-1439.e10. PubMed ID: 30593798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healthy HLA-DQ2.5+ Subjects Lack Regulatory and Memory T Cells Specific for Immunodominant Gluten Epitopes of Celiac Disease.
    Christophersen A; Risnes LF; Bergseng E; Lundin KE; Sollid LM; Qiao SW
    J Immunol; 2016 Mar; 196(6):2819-26. PubMed ID: 26895834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cells.
    de Kauwe AL; Chen Z; Anderson RP; Keech CL; Price JD; Wijburg O; Jackson DC; Ladhams J; Allison J; McCluskey J
    J Immunol; 2009 Jun; 182(12):7440-50. PubMed ID: 19494267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell response to gluten in patients with HLA-DQ2.2 reveals requirement of peptide-MHC stability in celiac disease.
    Bodd M; Kim CY; Lundin KE; Sollid LM
    Gastroenterology; 2012 Mar; 142(3):552-61. PubMed ID: 22108197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different binding motifs of the celiac disease-associated HLA molecules DQ2.5, DQ2.2, and DQ7.5 revealed by relative quantitative proteomics of endogenous peptide repertoires.
    Bergseng E; Dørum S; Arntzen MØ; Nielsen M; Nygård S; Buus S; de Souza GA; Sollid LM
    Immunogenetics; 2015 Feb; 67(2):73-84. PubMed ID: 25502872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DQ-Gluten Tetramer Blood Test Accurately Identifies Patients With and Without Celiac Disease in Absence of Gluten Consumption.
    Sarna VK; Lundin KEA; Mørkrid L; Qiao SW; Sollid LM; Christophersen A
    Gastroenterology; 2018 Mar; 154(4):886-896.e6. PubMed ID: 29146521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the binding of gluten T-cell epitopes to various human leukocyte antigen class II molecules.
    Bergseng E; Sidney J; Sette A; Sollid LM
    Hum Immunol; 2008 Feb; 69(2):94-100. PubMed ID: 18361933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transamidation of wheat flour inhibits the response to gliadin of intestinal T cells in celiac disease.
    Gianfrani C; Siciliano RA; Facchiano AM; Camarca A; Mazzeo MF; Costantini S; Salvati VM; Maurano F; Mazzarella G; Iaquinto G; Bergamo P; Rossi M
    Gastroenterology; 2007 Sep; 133(3):780-9. PubMed ID: 17678925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology of celiac disease.
    Koning F
    J Pediatr Gastroenterol Nutr; 2014 Jul; 59 Suppl 1():S1-4. PubMed ID: 24979191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A unique dendritic cell subset accumulates in the celiac lesion and efficiently activates gluten-reactive T cells.
    Ráki M; Tollefsen S; Molberg Ø; Lundin KE; Sollid LM; Jahnsen FL
    Gastroenterology; 2006 Aug; 131(2):428-38. PubMed ID: 16890596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two novel HLA-DQ2.5-restricted gluten T cell epitopes in the DQ2.5-glia-γ4 epitope family.
    Qiao SW; Sollid LM
    Immunogenetics; 2019 Nov; 71(10):665-667. PubMed ID: 31673720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DQ2-restricted gluten-reactive T cells produce IL-21 but not IL-17 or IL-22.
    Bodd M; Ráki M; Tollefsen S; Fallang LE; Bergseng E; Lundin KE; Sollid LM
    Mucosal Immunol; 2010 Nov; 3(6):594-601. PubMed ID: 20571486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of Gluten-Reactive T Cells in Active Celiac Lesions Estimated by Direct Cell Cloning.
    Qiao SW; Dahal-Koirala S; Eggesbø LM; Lundin KEA; Sollid LM
    Front Immunol; 2021; 12():646163. PubMed ID: 33796112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of tissue transglutaminase autoantibody levels by gluten-free diet is associated with changes in subsets of peripheral blood lymphocytes in children with newly diagnosed coeliac disease.
    Agardh D; Lynch K; Brundin C; Ivarsson SA; Lernmark A; Cilio CM
    Clin Exp Immunol; 2006 Apr; 144(1):67-75. PubMed ID: 16542367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A bispecific antibody targeting HLA-DQ2.5-gluten peptides potently blocks gluten-specific T cells induced by gluten ingestion in patients with celiac disease.
    Hardy MY; Henneken LM; Russell AK; Okura Y; Mizoroki A; Ozono Y; Kobayashi S; Murakami Y; Tye-Din JA
    Clin Immunol; 2024 Jul; 264():110259. PubMed ID: 38768856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the immune response to barley in celiac disease: Biased and public T-cell receptor usage to a barley unique and immunodominant gluten epitope.
    Dahal-Koirala S; Neumann RS; Jahnsen J; Lundin KEA; Sollid LM
    Eur J Immunol; 2020 Feb; 50(2):256-269. PubMed ID: 31628754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-chain recombinant HLA-DQ2.5/peptide molecules block α2-gliadin-specific pathogenic CD4+ T-cell proliferation and attenuate production of inflammatory cytokines: a potential therapy for celiac disease.
    Huan J; Meza-Romero R; Mooney JL; Vandenbark AA; Offner H; Burrows GG
    Mucosal Immunol; 2011 Jan; 4(1):112-20. PubMed ID: 20736999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent insight in the pathophysiology of coeliac disease: relevance to rheumatoid arthritis.
    Koning F
    Clin Exp Rheumatol; 2015; 33(4 Suppl 92):S8-10. PubMed ID: 26457726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.